Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
B20020076	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Import Drug Application	2002-07-15	葛兰素史克(中国)投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Approval Completed-Pending Certificated	2002-12-02	view
JYHZ0900226	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	License Renew	2009-07-24	Glaxo Group Ltd.	Glaxo Group Ltd	Certificate Issued	2010-08-17	view
JYHB1000961	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2010-11-11	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2011-05-25	view
JYHB1200995	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2012-09-29	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2013-04-15	view
JYHB1400097	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2014-02-13	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2014-08-13	view
JYHB1502603	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2016-01-15	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2017-05-04	view
JYHB1600363	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2016-03-30	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2017-03-23	view
JYHB1701367	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2017-11-02	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Filed	2017-11-16	view
JYHB2001976	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2020-10-13	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Filed	2020-10-30	view
JYHB2002021	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2020-10-15	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Filed	2020-11-05	view
JYHB2002745	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2021-01-01	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2021-02-01	view
JYHZ2100553	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	License Renew	2021-06-07					view
JYHB2101160	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2021-06-11					view
JYHB2200481	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2022-09-03					view
JYHB2300661	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs	Supplementary Application	2023-11-17					view
CYHS2303477	硫酸阿巴卡韦片	abacavir sulfate	Tablet	Chemical Drugs(4)	Generic Drug	2023-12-14		Shanghai DESANO Biopharmaceutical Co Ltd			view